On a filed basis, annual sales rose from KRW 12.5 billion in 2022 to KRW 13.7 billion in 2023 (up 9.6% year on year) and KRW 14.7 billion in 2024 (up 7.3%), then fell to KRW 13.4 billion in 2025 (down 9.1%). Among 2022 to 2025, 2024 was the largest year and 2022 the smallest.
Operating profit fell from KRW 1.78 billion in 2022 to KRW 1.5 billion in 2023 (down 15.6%), and the company recorded an operating loss of KRW 236 million in 2024, its first loss year in this period. In 2025 the operating loss widened to KRW 1.53 billion.
The operating margin went from 14.2% in 2022 and 10.9% in 2023 to -1.6% in 2024 and -11.4% in 2025. In a June 2026 report, Kiwoom Securities said weakness in research-market demand has persisted and that R&D costs for new equipment widened the loss.
Net profit attributable to controlling shareholders was KRW 1.72 billion in 2022, KRW 1.68 billion in 2023 (down 1.8%), and KRW 1,000 million in 2024 (down 40.6%), then turned into a net loss of KRW 652 million in 2025.
Total net income, including non-controlling interests, was KRW 664 million in 2024 and a net loss of KRW 871 million in 2025, a different figure from net profit attributable to controlling shareholders.
Operating cash flow was KRW 1.91 billion in 2022, then -KRW 142 million in 2023, -KRW 421 million in 2024, and -KRW 520 million in 2025. On a quarterly basis, 4Q 2025 sales reached KRW 4.81 billion (up 91.7% quarter on quarter) and operating profit was KRW 318 million, a swing to profit.
Net profit attributable to controlling shareholders of KRW 844 million in that quarter exceeded operating profit, so non-operating items had a large effect. 1Q 2026 sales fell 47.6% quarter on quarter to KRW 2.52 billion, with an operating loss of KRW 1.08 billion. 2Q 2026 sales were KRW 2.72 billion (up 7.8% quarter on quarter and down 6.8% year on year), and the operating loss narrowed to KRW 741 million, but losses have continued for two quarters since 1Q 2026.
The combined net loss attributable to controlling shareholders over the last four quarters, from 3Q 2025 to 2Q 2026, was KRW 925 million.